Biggest Stock Gainers 3/9/09 March 9, 2009

Today, March 9, 2009, there are several stock gainers that are breaking out with some nice momentum. If you are looking to day trade today, you might want to check out the following stocks. Check out today's biggest gainers and the Top Stocks for 2009. You can find yesterday's Top Gainers Report Right Here

Hot Stocks 3/9/09 - Biggest Gainers Today


Stem Cells ( STEM ) - $2.18 Up 58% - STEM is going due to the Obama stem cell funding decision. Stem is a little lower from earlier pre market highs.

Geron ( GERN ) - $5.00 Up 29% - Because of the above stem cell news

Cytori ( CYTX ) - $3.00 Up 29.87% - Because of the above stem cell news

American Oriental Bioengineering (AOB) - $4.18 Up 22.22% - American Oriental Bioengineering to Initiate a Phase One Clinical Trial in the United States of AOBO-001 Oral Capsule.

Ultra Short Real Estate ETF ( SRS ) - $105.00 Up 5.75%


Today's Biggest Stock Market Gainers - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Baltic Dry Index

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free

Stem Cell Stocks 3/9/09 March 9, 2009

The following Stem Cell stocks will be higher today due to the decision from Barack Obama to overturn the block on government funding for embryonic stem cell research. White House officials said Sunday that the president's order will give the National Institutes of Health 120 days to develop ethical guidelines for the research.


Stem Cell Stocks March 9, 2009 - Pre Market

Stem Cells ( STEM ) - $2.21 Up 60.14%
Geron ( GERN ) - $5.10 Up 31.78%
Aastrom Biosciences ( ASTM ) - $0.63 Up 90.91%
Pluristem Therapeutics (PSTI) - $1.23 Up 15%
Opexa Theraputics ( OPXA ) - $0.55 Up 83.33%
Thermogenesis ( KOOL ) - $0.60 Up 49.25%
Cytori Therapeutics ( CYTX ) - $3.30 Up 42.86%

Today's Biggest Stock Market Gainers - Top 2009 Stock Gainers - Top 2009 Penny Stocks - Baltic Dry Index

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free

Biggest Stock Gainers 1/26/09 - January 26, 2009

Today, January 26, 2009, their are several stocks gainers that are breaking out in the stock market despite the fact that we are approaching the lows for the day. Check out today's biggest gainers and the Top Stocks for 2009.

Hot Stocks 1/26/09 - Biggest Gainers Today

Barclays ( BCS ) - $4.92 Up 60.17% - Barclays stock surges after profit reassurance.

Allied Irish Banks ( AIB ) - $2.80 Up 35% - AIB is going up with the above Barclays news.

Ouiksilver ( ZQK ) - $2.07 Up 37.02% - Quiksilver stock is surging on speculation of a takeover by another company.

Geron ( GERN ) - $7.87 Up 11% - GERN continues to soar on the FDA Stem Cell News which was released Friday.

Stem Cells ( STEM ) - $2.69 Up 6.32% - STEM continues to soar on the above Geron news and is up 14 of the past 16 trading sessions. STEM has become an explosive stock and is one of 2009's Top Stock Gainers.

Other Stocks doing well - DRYS, ASTM, FCX, ING, GASS

For More Stock Market Updates, visit , http://daytradingstockblog.blogspot.com/ or Subscribe for FREE

Biggest Stock Gainers 1/23/09 - January 23, 2009

Today, January 23, 2009, their are several stocks gainers that are breaking out in the stock market despite the weakness we are seeing in the major averages. Check out today's biggest gainers and the Top Stocks for 2009.

Hot Stocks 1/23/09 - Biggest Gainers

Geron ( GERN ) - $6.97 Up 33.78% - Geron received FDA Approval for the World's first clinical trial involving humans and Stem Cell Research. The CEO was on CNBC earlier in the day.

Stem Cells ( STEM ) - $2.63% Up 22% - Stem Cells is up on the above GERN news - Also up on this news is ASTM Aastom Biosciences. The Stem Cell Stocks are very hot today! We noted this yesterday!

Satyam ( SAY ) - $1.35 Up 26.16% - Satyam Board Announces Key Actions.


For More Stock Market Updates, visit , http://daytradingstockblog.blogspot.com/ or Subscribe for FREE

Geron GERN Stem Cell Stocks 1/23/09

Geron ( GERN ) is out with Stem Cell news this morning, January 23, 2009 - as this company will be the first company testing a human in the world's first human clinical trial involving Stem Cells. Under the new Obama administration, the FDA has approved this trial in which the Bush administration wasn't allowing Government funding for Stem Cell Research.

GERN stock is exploding higher today, to $6.48 Up 24%. Other Stem Cell stocks are higher such as Stem Cells ( STEM ) and Aastrom Biosciences ( ASTM )

Geron Corporation (Nasdaq: GERN) announced today that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of GRNOPC1 in patients with acute spinal cord injury.
The clearance enables Geron to move forward with the world's first study of a human embryonic stem cell (hESC)-based therapy in man. Geron plans to initiate a Phase I multi-center trial that is designed to establish the safety of GRNOPC1 in patients with "complete" American Spinal Injury Association (ASIA) grade A subacute thoracic spinal cord injuries.

"The FDA's clearance of our GRNOPC1 IND is one of Geron's most significant accomplishments to date," said Thomas Okarma, Ph.D., M.D., Geron's president and CEO. "This marks the beginning of what is potentially a new chapter in medical therapeutics - one that reaches beyond pills to a new level of healing: the restoration of organ and tissue function achieved by the injection of healthy replacement cells. The ultimate goal for the use of GRNOPC1 is to achieve restoration of spinal cord function by the injection of hESC-derived oligodendrocyte progenitor cells directly into the lesion site of the patient's injured spinal cord."

GRNOPC1, Geron's lead hESC-based therapeutic candidate, contains hESC-derived oligodendrocyte progenitor cells that have demonstrated remyelinating and nerve growth stimulating properties leading to restoration of function in animal models of acute spinal cord injury (Journal of Neuroscience, Vol. 25, 2005).

"The neurosurgical community is very excited by this new approach to treating devastating spinal cord injury," said Richard Fessler, M.D., Ph.D., professor of neurological surgery at the Feinberg School of Medicine at Northwestern University. "Demyelination is central to the pathology of the injury, and its reversal by means of injecting oligodendrocyte progenitor cells would be revolutionary for the field. If safe and effective, the therapy would provide a viable treatment option for thousands of patients who suffer severe spinal cord injuries each year."

Full Article - http://www.geron.com/media/pressview.aspx?id=863

For More Stock Market Updates, visit , http://daytradingstockblog.blogspot.com/ or Subscribe for FREE

Today's Biggest Gainers 12/18/08 DVAX STEM

This morning, 12/18/08, we have several hot stocks breaking out to the upside. It seems as though all the penny stocks are the biggest gainers this week. I haven't seen so many penny stocks on the top gainers list in awhile.

Hot Stocks to Watch - December 18, 2008

Dynavax ( DVAX ) - DVAX is at it again, after soaring yesterday, this stock is over $2 in pre market trading on partnership news with GSX.

Stem Cells ( STEM ) - STEM received FDA Approval to start a clinical trial.

Avigen ( AVGN ) - Selling rights of a research program to Baxter for $7 million.

http://www.blackberrystocks.com/hotstocks.html

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free

Stem Cells STEM FDA Approval 12/18/08

Expect Stem Cells ( STEM ) to be a big gainer today, 12/18/08, as this company received FDA Approval to initiate a clinical trial of the Company’s proprietary HuCNS-SC product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a fatal brain disorder that mainly affects young children. This Phase I trial is designed to evaluate the safety and preliminary efficacy of HuCNS-SC cells as a treatment for PMD. Currently, there are no approved treatments for this disease.

This is the Company’s second FDA-approved clinical trial to evaluate HuCNS-SC cells as a potential treatment for neurodegenerative diseases. The first such study was the Company’s Phase I clinical trial of HuCNS-SC cells to treat neuronal ceroid lipofuscinoses (NCL), or Batten disease. The Phase I NCL trial will be completed in January 2009.

Patients with PMD are born with a gene mutation that results in insufficient myelination of nerve fibers in the brain, neurological impairment and eventually death. Myelin, which is produced by special cells called oligodendrocytes, insulates nerve fibers to allow electrical signals to be conducted normally. Other, more common, myelination diseases include cerebral palsy, transverse myelitis and multiple sclerosis

STEM is up 16% to $1.54 in pre market trading.

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free

Dow Jones Close 12/9/08 - Stock Market Closing Prices

Stock Market Closing Prices - 12/09/08

Dow Jones Industrial Average ( DJIA ) Close - 8691.33 Down 242.85
Nasdaq Stock Market Close - 1547.34 Down 24.40
S&P 500 Close - 888.65 Down 21.05

Libor Rates - 12/09/08

1 Month - 1.64%
3 Month - 2.16%

Commodities Closing Prices - 12/09/08

Gold - 776
Oil - 42.25
Natural Gas - 5.61

The Dow Jones Industrial Average closed at 8691 on 12/09/08, as investors took profits after a horrible outlook from Fedex ( FDX ) . The Stock Market Futures were down to flat this morning and when the Stock Market opened, the Dow Jones never really managed to go positive but the Nasdaq was up 35 at one point. The technology sector was very strong. One of the biggest gainers for the second straight day was DryShips ( DRYS ). This sector has been so oversold that a bounce was more then overdue. The volume in all the bulk shipping stocks was very high today, a good sign. The S&P 500 was fairly strong during the day but slipped below 900 is afternoon trading. At 3:26pm today, Wal Mart ( WMT ) has announced that they are suspending their share repurchase program. This is interesting news and is adding pressure to the Dow Jones Industrial Average. WMT stock is down 3.0% today. Could this signal Wal Mart is ready to buy another company? I will have technical analysis of the Nasdaq and Dow Jones, later, right HERE

Today's Biggest Gainers - December 9th, 2008
Top 2008 Stocks Year to Date

For the latest updates on the stock market, visit, http://daytradingstockblog.blogspot.com/ or Subscribe for Free

Stem Cell ( STEM ) 11/10/08 Breakout Stock

Stem Cells ( STEM ) is breaking out today, 11/10/08, up 40% to $2.40. If you can recall, last week I mentioned that if STEM broke $2.28 it would rip higher. We are seeing that this morning as the volume has picked up since the break above $2.28. STEM is one to watch because if this stock can get some volume, it could really be a day traders delight. Support is at $2.28, Resistance is at $2.53.

Also, watch LVS for a break above $7.20 and $7.60, that could get Las vegas Sands running again.

http://daytradingstockblog.blogspot.com/

Stem Cell Stocks: 11/03/08 - STEM, ASTM, GERN

The Stem Cell stocks are exploding 11/03/08, the day before the Presidential Election as the polls favor Obama as the next President. The following Stem Cell stocks are ones I will be watching:

Stem Cells ( STEM ) $2.05 +42%
Aastrom Biosciences ( ASTM ) $.50 +25.61%
Geron ( GERN ) $4.30 +8%

Last Election, these three stocks exploded in anticipation Al Gore would win, and then they crashed when he didn't. If Obama wins, these three could see further upside.

http://daytradingstockblog.blogspot.com/